University of South Florida

Digital Commons @ University of South Florida
Molecular Pharmacology & Physiology Faculty
Publications

Molecular Pharmacology & Physiology

2017

The Real Culprit Behind Diabetic Nephropathy: Impaired Renal
Autoregulation?
Ruisheng Liu
University of South Florida, ruisheng@usf.edu

Follow this and additional works at: https://digitalcommons.usf.edu/mpp_facpub
Part of the Pharmacy and Pharmaceutical Sciences Commons

Scholar Commons Citation
Liu, Ruisheng, "The Real Culprit Behind Diabetic Nephropathy: Impaired Renal Autoregulation?" (2017).
Molecular Pharmacology & Physiology Faculty Publications. 2.
https://digitalcommons.usf.edu/mpp_facpub/2

This Article is brought to you for free and open access by the Molecular Pharmacology & Physiology at Digital
Commons @ University of South Florida. It has been accepted for inclusion in Molecular Pharmacology &
Physiology Faculty Publications by an authorized administrator of Digital Commons @ University of South Florida.
For more information, please contact scholarcommons@usf.edu.

Physiological Reports ISSN 2051-817X

EDITORIAL

The real culprit behind diabetic nephropathy: impaired
renal autoregulation?
Ruisheng Liu
Department of Molecular Pharmacology & Physiology, University of South Florida College of Medicine, Tampa, Florida
E-mail: ruisheng@health.usf.edu

doi: 10.14814/phy2.13138

More than 29 million of Americans have diabetes. About
30–40% of the diabetic patients will eventually develop
diabetic nephropathy (DN), which is the leading cause of
end-stage renal disease (Centers for Disease Control and
Prevention, 2014; United States Renal Data System.,
2012). Control of blood pressure (BP) and blood glucose
has been shown to reduce the risk of developing DN
(Nathan 2014). However, not all patients with poor control in BP and plasma glucose will develop renal disease.
On the other hand, over 1/3 of patients with type 2 diabetes develop DN despite strict control of BP and/or
blood glucose (Mooyaart 2014; Tomino and Gohda
2015). Therefore, further understanding the pathophysiological mechanisms underlying the DN is essential to
identify potential target for treatment.
Many studies demonstrated an association between
glomerular capillary hypertension and diabetes-associated
kidney disease. An elevated glomerular capillary pressure
was first reported in experimental diabetic Munich-Wistar
rats in 1980s (Hostetter et al. 1982). In physiological conditions, glomerular capillary pressure is well-maintained
within a normal range by a renal autoregulatory mechanism, by which the renal blood flow (RBF) and glomerular filtration rate (GFR) maintain constant and are
independent of systemic blood pressure over a wide
range. While its mechanism and significance have not
been fully elucidated, renal autoregulation is considered
an essential mechanism to keep constant electrolytes
delivery to distal nephrons and sustain normal kidney
clearance function facing fluctuations in systemic blood
pressure. Renal autoregulation is also proposed to be a
unique self-protective mechanism of the kidney in our
body, which isolate fluctuations in systemic blood pressure and keep a relatively constant level in intraglomerular capillary pressure that may prevent glomerular
injuries. The renal autoregulation is believed to be mainly
mediated by myogenic response of the afferent arteriole
and tubuloglomerular feedback (TGF) response. Myogenic
response is rapid response of vasoconstriction of the afferent arteriole in response to an increase in transmural

pressure. TGF response refers a negative feedback mechanism that increased NaCl delivery to the macula densa
promotes release of adenosine and/or ATP, which constricts the afferent arteriole and decreases single nephron
GFR (Burke et al. 2014).
Impaired autoregulation has been proposed to play an
important role in the development of kidney injury by
elevation of glomerular capillary pressure in hypertensive
experimental models. Typical examples are Dahl salt-sensitive rats and spontaneously hypertensive (SHR) rats.
Dahl salt-sensitive rats exhibit impaired autoregulation
and are sensitive to diabetic kidney injury, whereas SHR
rats show intact autoregulation and are resistant to diabetic kidney injury in the present of hypertension
(Slaughter et al. 2013). However, whether the impaired
autoregulation itself without hypertension induces diabetic kidney injury remains elusive. It has long been
reported that Milan normotensive strain (MNS) of rats
develops progressive proteinuria and glomerular injury
following the induction of diabetes with streptozotocin
(STZ) (Pugliese et al. 2005) in the absence of systemic
hypertension. In contract, Milan hypertensive strain
(MHS) of rats is resistant to the development of proteinuria and kidney injury. The mechanisms underlying have
not been clarified.
A recent study by Ge et al. (2016) provided a potential
mechanism for the difference in diabetes-associated kidney injury between MNS and MHS rats. They demonstrated that normotensive rats with impaired
autoregulation developed severe diabetic kidney injury, in
contrast, the hypertensive rats with intact autoregulation
were protected from diabetic kidney injury. Renal
autoregulation was evaluated by measurement of myogenic response of the afferent arteriole (Af-Art), RBF and
stop-flow pressure of proximal tubule when perfusion
pressure was increased in MNS and MHS rats. While
MHS exhibited efficient renal autoregulatory function,
autoregulation in MNS was impaired. Then type 1 diabetes was induced with STZ and plasma glucose levels
were maintained at a similar level in both groups of
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animals. After 21 weeks of induction of diabetes, MAP
was over 20 mmHg higher in MHS than MNS rats. The
MNS rats developed severe diabetic kidney injury
reflected by proteinuria, plasma creatinine, and renal histology. However, the MHS rats were largely protected
from renal injury. This study highlighted the essential role
of renal autoregulation in the development of diabetic
kidney injury independent of hypertension. Unlike in
Munich-Wistar rats, glomerular capillary pressure is difficult to be measured directly in most other strains of
rodents with micropuncture since the glomeruli are not
visible on the kidney surface. Thereby, stop-flow pressure
was used as a surrogate for glomerular capillary pressure
in this study. It should be aware that the using stop-flow
pressure for evaluation of autoregulation excludes the
contribution of TGF response. Thereby the impairment of
autoregulation could be underestimated if both myogenic
response and TGF response are impaired in MNS. Actually, the results of RBF implied this possibility. RBF raised
about 40%, whereas stop-flow pressure only elevated by
about 20% when renal perfusion pressure increased from
100 to 140 mmHg (Ge et al. 2016).
Considering still no efficient treatment for DN exist,
therefore, we are speculating that in the prevention and
treatment of diabetic nephropathy we might have been
shooting the wrong targets by focusing on accomplices
such as hypertension, hyperglycemia, dyslipidemia,
obesity, and insulin resistance, but missed the real culprit
– the impaired renal autoregulation. Candidates for regulation of renal autoregulation include but are not limited
to Adducin-3 gene (Burke et al. 2013) and TRP channels
(Carlstrom et al. 2015) for myogenic response of the AfArt and NOS1 splice variants in the macula densa for
TGF responsiveness (Lu et al. 2010, 2016). These candidates may be regulated by both genetic and environmental factors and could be potential targets for the
prevention and treatment for DN.
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